| Tanaka C, Yin OQ, Sethuraman V, et al.
Clinical Pharmacokinetics of the BCR-ABL Tyrosine Kinase Inhibitor Nilotinib. [JOURNAL ARTICLE]
Clin Pharmacol Ther 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Manley PW, Drueckes P, Fendrich G, et al.
Extended kinase profile and properties of the protein kinase inhibitor Nilotinib. [JOURNAL ARTICLE]
Biochim Biophys Acta 2009 Nov 13.
Abstract | Full Citation | Find Related Articles | | Swords R, Mahalingam D, Padmanabhan S, et al.
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:89-101.
Abstract | Full Citation | Find Related Articles | | Fava C, Kantarjian H, Cortes J, et al.
Development and targeted use of nilotinib in chronic myeloid leukemia. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:233-243.
Abstract | Full Citation | Find Related Articles | | Huang X, Patel S, Ahmed N, et al.
Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:215-219.
Abstract | Full Citation | Find Related Articles | | Masiello D, Gorospe G, Yang AS
The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib. [JOURNAL ARTICLE]
J Hematol Oncol 2009 Nov 12; 2(1):46.
Abstract | Full Citation | Find Related Articles | | Miura M, Takahashi N, Sawada KI
High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma. [JOURNAL ARTICLE]
Biomed Chromatogr 2009 Nov 10.
Abstract | Full Citation | Find Related Articles | | Zhou T, Commodore L, Huang WS, et al.
Structural Analysis of DFG-in and DFG-out Dual Src-Abl Inhibitors Sharing a Common Vinyl Purine Template. [JOURNAL ARTICLE]
Chem Biol Drug Des 2009 Nov 5.
Abstract | Full Citation | Find Related Articles | | Rix U, Remsing Rix LL, Terker AS, et al.
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells. [JOURNAL ARTICLE]
Leukemia 2009 Nov 5.
Abstract | Full Citation | | Cooper S, Giles FJ, Savona MR
Overcoming resistance in chronic myelogenous leukemia. [Journal Article]
Leuk Lymphoma 2009 Nov; 50(11):1785-93.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
